References

Ali S, Dave N, Virani SS, Navaneethan SD. Primary and secondary prevention of cardiovascular disease in patients with chronic kidney disease. Curr Atheroscler Rep. 2019; 21:(9) https://doi.org/10.1007/s11883-019-0794-6

Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in low- and middle-income countries: a call for urgent action. Kidney Int Rep. 2020; 5:(3)255-262 https://doi.org/10.1016/j.ekir.2019.12.013

Apuzzo L, Murphy F. Cardiovascular risk in chronic kidney disease. In: Drahne A (ed). Hergiswil, Switzerland: European Dialysis and Transplant; 2021

Association of British Clinical Diabetologists, Renal Association. ABCD and Renal Association clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease (DKD). 2021. https://tinyurl.com/2twff7b2 (accessed 2 October 2023)

Baker LA, March DS, Wilkinson TJ Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC Nephrol. 2022; 23:(1) https://doi.org/10.1186/s12882-021-02618-1

Banerjee S, Panas R. Diabetes and cardiorenal syndrome: understanding the ‘triple threat’. Hellenic J Cardiol. 2017; 58:(5)342-347 https://doi.org/10.1016/j.hjc.2017.01.003

Bays HE, Kulkarni A, German C Ten things to know about ten cardiovascular disease risk factors—2022. Am J Prev Cardiol. 2022; 10 https://doi.org/10.1016/j.ajpc.2022.100342

Bikbov B, Purcell CA, Levey AS Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395:(10225)709-733 https://doi.org/10.1016/S0140-6736(20)30045-3

How to help people with diabetes stop smoking. 2021. https://tinyurl.com/3tcwzxtt (accessed 25 September 2023)

Campagna D, Alamo A, Di Pino A Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019; 11:(1) https://doi.org/10.1186/s13098-019-0482-2

Davies MJ, Aroda VR, Collins BS Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022; 45:(11)2753-2786 https://doi.org/10.2337/dci22-0034

de Boer IH, Khunti K, Sadusky T Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022; 45:(12)3075-3090 https://doi.org/10.2337/dci22-0027

Diabetes.co.uk. Dehydration and diabetes. 2019. https://www.diabetes.co.uk/dehydration-and-diabetes.html (accessed 25 September 2023)

Diabetes UK. Diabetes when you're unwell. 2020. https://tinyurl.com/2p8j4vdk (accessed 25 September 2023)

Diabetes UK. Alcohol and diabetes. 2022. https://tinyurl.com/54fafpcz (accessed 25 September 2023)

Diabetes UK. Ethnicity and type 2 diabetes. 2023a. https://tinyurl.com/2jmc2t7v (accessed 2 October 2023)

Diabetes UK. Number of people living with diabetes in the UK tops 5 million for the first time. 2023b. https://tinyurl.com/mrjzwy4y (accessed 25 September 2023)

Diabetes UK. Weight loss can put type 2 diabetes into remission for at least 5 years, direct study reveals. 2023c. https://tinyurl.com/5n6pe5uf (accessed 25 September 2023)

ElSayed NA, Aleppo G, Aroda VR 5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes–2023. Diabetes Care. 2023a; 46:S68-S96 https://doi.org/10.2337/dc23-S005

ElSayed NA, Aleppo G, Aroda VR Summary of revisions: Standards of Care in Diabetes–2023. Diabetes Care. 2023b; 6:S5-S9 https://doi.org/10.2337/dc23-Srev

Evangelidis N, Craig J, Bauman A, Manera K, Saglimbene V, Tong A. Lifestyle behaviour change for preventing the progression of chronic kidney disease: a systematic review. BMJ Open. 2019; 9:(10) https://doi.org/10.1136/bmjopen-2019-031625

Farsalinos KE, Romagna G, Tsiapras D Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health. 2014; 11:(4)4356-4373 https://doi.org/10.3390/ijerph110404356

Formanek P, Salisbury-Afshar E, Afshar M. Helping patients with ESRD and earlier stages of CKD to quit smoking. Am J Kidney Dis. 2018; 72:(2)255-266 https://doi.org/10.1053/j.ajkd.2018.01.057

Forst T, Mathieu C, Giorgino F New strategies to improve clinical outcomes for diabetic kidney disease. BMC Med. 2022; 20:(1) https://doi.org/10.1186/s12916-022-02539-2

Ghane Shahrbaf F, Assadi F. Drug-induced renal disorders. J Renal Inj Prev. 2015; 4:(3)57-60 https://doi.org/10.12861/jrip.2015.12

Hahr AJ, Molitch ME. Management of diabetes mellitus in patients with CKD: core curriculum 2022. Am J Kidney Dis. 2022; 79:(5)728-736 https://doi.org/10.1053/j.ajkd.2021.05.023

UKKA clinical practice guideline: Sodium-glucose co-transporter-2 (SGLT-2) inhibition in adults with kidney disease. 2021. https://tinyurl.com/4uzrzeue (accessed 25 September 2023)

International Diabetes Federation. IDF diabetes atlas. 2021. https://tinyurl.com/2uxcewa7 (accessed 25 September 2023)

Karunathilake SP, Ganegoda GU. Secondary prevention of cardiovascular diseases and application of technology for early diagnosis. Biomed Res Int. 2018; 2018 https://doi.org/10.1155/2018/5767864

Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. 2013. https://tinyurl.com/jdpfdu6p (accessed 25 September 2023)

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022; 12:(1)7-11 https://doi.org/10.1016/j.kisu.2021.11.003

Lameire NH, Levin A, Kellum JA Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021; 100:(3)516-526 https://doi.org/10.1016/j.kint.2021.06.028

Diabetic kidney disease. 2023. https://bestpractice.bmj.com/topics/en-gb/530 (accessed 25 September 2023)

Murphy F, Apuzzo L. The impact of diabetes mellitus on chronic kidney disease progression. In: Drahne A (ed). Hergiswil, Switzerland: European Dialysis and Transplant Nurses Association/European Renal Care Association; 2021

Murphy F, Byrne G. Promoting kidney health in cardiovascular disease: part one. British Journal of Cardiac Nursing. 2022a; 17:(10)1-12 https://doi.org/10.12968/bjca.2022.0083

Murphy F, Byrne G. Promoting kidney health in cardiovascular disease: part two. Br J Card Nurs. 2022b; 17:(12)1-11 https://doi.org/10.12968/bjca.2022.0111

Musso CG, Rosell C, Gonzalez-Torres H, Ordonez JD, Aroca-Martinez G. Primary prevention for acute kidney injury in ambulatory patients. Postgrad Med. 2020; 132:(8)746-748 https://doi.org/10.1080/00325481.2020.1795484

National Institute for Health and Care Excellence. Prescribing in renal impairment. 2019. https://bnf.nice.org.uk/medicines-guidance/prescribing-in-renal-impairment (accessed 25 September 2023)

National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management. NICE guideline NG203. 2021. https://www.nice.org.uk/guidance/ng203 (accessed 25 September 2023)

National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline NG28. 2022. https://www.nice.org.uk/guidance/ng28 (accessed 25 September 2023)

National Institute for Health and Care Excellence. Diabetes – type 2. Clinical knowledge summary. 2023. https://cks.nice.org.uk/topics/diabetes-type-2 (accessed 25 September 2023)

Obesity Medicine Association. Obesity algorithm. Important principles for the effective treatment of patients with obesity. 2023. https://obesitymedicine.org/obesity-algorithm (accessed 25 September 2023)

Rossing P, Caramori ML, Chan JCN Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022; 102:(5)990-999 https://doi.org/10.1016/j.kint.2022.06.013

Sikand G, Severson T. Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction. American Journal of Preventive Cardiology. 2020; 4 https://doi.org/10.1016/j.ajpc.2020.100106

Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017; https://doi.org/10.1177/2048004016687211

United Kingdom Kidney Association. CKD stages. 2022. https://tinyurl.com/mwrk6w57 (accessed 25 September 2023)

Visseren FL, Mach F, Smulders YM ESC guidelines on cardiovascular disease prevention in clinical practice: developed by the task force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2021; 42:(34)3227-3337 https://doi.org/10.1093/eurheartj/ehab484

World Health Organization. Toolkit for delivering the 5A's and 5R's brief tobacco interventions in primary care. 2014. https://apps.who.int/iris/handle/10665/112835 (accessed 25 September 2023)

Wright M, Southcott E, MacLaughlin H, Wineberg S. Clinical practice guideline on undernutrition in chronic kidney disease. BMC Nephrol. 2019; 20:(1) https://doi.org/10.1186/s12882-019-1530-8

Diabetes

Promoting kidney health in people with type 2 diabetes: part 1

12 October 2023
Professional
02 October 2023
Volume 32 · Issue 18

Abstract

The incidence of chronic kidney disease is increasing internationally with risk factors for the condition being the same as those for type 2 diabetes. It is important therefore for nurses to use primary, secondary and tertiary prevention to minimise the incidence of chronic kidney disease when caring for individuals with type 2 diabetes. This article is the first of a two-part series on the interrelationship between these long-term conditions. This article, part 1, addresses the significance of primary prevention in promoting kidney health in adults living with type 2 diabetes, while part 2 will discuss the use of secondary and tertiary prevention relevant to these long-term conditions.

This article will examine the strong interconnection between chronic kidney disease (CKD) and type 2 diabetes and the importance of promoting kidney health. First, it will describe CKD and type 2 diabetes along with their prevalence. It will then discuss the importance of primary preventive measures and provide examples to assist nurses and other multidisciplinary team members in primary or community care as well as those in secondary or hospital care settings to promote kidney health with adults living with type 2 diabetes. Diabetes is known to be independently associated with CKD as well as cardiovascular disease (CVD) so is known as a triple threat (Banerjee and Panas, 2017).

It is important to be mindful of the interrelationship between these long-term conditions. Promoting kidney health is relevant to not only diabetic health but also heart health. Nurses should take every opportunity to work with individuals to educate and empower them to make informed and active choices surrounding their health outcomes and life goals while living daily with these long-term conditions (Murphy and Byrne, 2022a; 2022b).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content

Register
Or continue by

Signing in with your registered email address

Health promotion
Primary prevention
Type 2 diabetes
Chronic kidney disease
Cardiovascular disease
Education